Filing Flows › Comparisons › PHAT vs AUPH
Phathom Pharmaceuticals vs Aurinia Pharmaceuticals: PHAT and AUPH compared
Phathom Pharmaceuticals is the larger company: $84.7M of revenue in its latest quarter (Q3 2026) against $83.7M for Aurinia Pharmaceuticals (Q3 2026). Phathom Pharmaceuticals is growing faster (+71% against +14% a year earlier). Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against -0.1%.
Where the money goes: PHAT and AUPH
Phathom Pharmaceuticals (PHAT) · Q3 2026
Phathom Pharmaceuticals, Q3 2026: revenue $84.7M (+71% year over year), operating margin -0.1%, net loss $13.9M, operating cash flow $1.8M. The chart follows the revenue to costs, profit and cash.
Aurinia Pharmaceuticals (AUPH) · Q3 2026
Aurinia Pharmaceuticals, Q3 2026: revenue $83.7M (+14% year over year), operating margin 42.3%, net earnings $31.7M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
| Phathom Pharmaceuticals (PHAT) | Aurinia Pharmaceuticals (AUPH) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $84.7M | $83.7M |
| Revenue growth, Y/Y | +71% | +14% |
| Operating margin | -0.1% | 42.3% |
| Net earnings | −$13.9M | $31.7M |
| Net margin | -16.4% | 37.9% |
| Operating cash flow | $1.8M | $46.4M |
| Free cash flow | $1.7M | — |
| Market value | — | $2.2B |
| P/E | — | 7.2× |
| Analysts’ mean target | — | $18.29 |
Where the revenue comes from
Aurinia Pharmaceuticals
- Net product sales: $79.4M (95%)
- License, collaboration and royalty revenue: $4.3M (5%)
Questions
Which is bigger, Phathom Pharmaceuticals or Aurinia Pharmaceuticals?
Phathom Pharmaceuticals is the larger company: $84.7M of revenue in its latest quarter (Q3 2026) against $83.7M for Aurinia Pharmaceuticals (Q3 2026).
Is Phathom Pharmaceuticals or Aurinia Pharmaceuticals growing faster?
Phathom Pharmaceuticals is growing faster (+71% against +14% a year earlier).
Which is more profitable, Phathom Pharmaceuticals or Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against -0.1%.
More: Phathom Pharmaceuticals earnings · how Phathom Pharmaceuticals makes money · Aurinia Pharmaceuticals earnings · how Aurinia Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.